These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16981823)

  • 1. Targeting the CB2 receptor for immune modulation.
    Lunn CA; Reich EP; Bober L
    Expert Opin Ther Targets; 2006 Oct; 10(5):653-63. PubMed ID: 16981823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updating the chemistry and biology of cannabinoid CB2 receptor-specific inverse agonists.
    Lunn CA
    Curr Top Med Chem; 2010; 10(8):768-78. PubMed ID: 20370714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.
    Rizzo MD; Henriquez JE; Blevins LK; Bach A; Crawford RB; Kaminski NE
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):780-793. PubMed ID: 32409991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and biochemical analyses of selective CB
    Scott CE; Tang Y; Alt A; Burford NT; Gerritz SW; Ogawa LM; Zhang L; Kendall DA
    Eur J Pharmacol; 2019 Jul; 854():1-8. PubMed ID: 30951717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
    Bab I; Zimmer A; Melamed E
    Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors.
    Gertsch J; Raduner S; Altmann KH
    J Recept Signal Transduct Res; 2006; 26(5-6):709-30. PubMed ID: 17118807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Cannabinoids on T-cell Function and Resistance to Infection.
    Eisenstein TK; Meissler JJ
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):204-16. PubMed ID: 25876735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel azoles as potent and selective cannabinoid CB2 receptor agonists.
    Harnett JJ; Dolo C; Viossat I; Auger F; Ferrandis E; Bigg D; Auguet M; Auvin S; Chabrier PE
    Bioorg Med Chem Lett; 2015 Jan; 25(1):88-91. PubMed ID: 25466197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study.
    Giacoppo S; Gugliandolo A; Trubiani O; Pollastro F; Grassi G; Bramanti P; Mazzon E
    Eur J Histochem; 2017 Jan; 61(1):2749. PubMed ID: 28348416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual Screening of
    Mizera M; Latek D; Cielecka-Piontek J
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Fu W; Taylor BK
    Neurosci Lett; 2015 May; 595():1-6. PubMed ID: 25849525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
    Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
    Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation.
    Palazuelos J; Aguado T; Egia A; Mechoulam R; Guzmán M; Galve-Roperh I
    FASEB J; 2006 Nov; 20(13):2405-7. PubMed ID: 17015409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
    Rieder SA; Chauhan A; Singh U; Nagarkatti M; Nagarkatti P
    Immunobiology; 2010 Aug; 215(8):598-605. PubMed ID: 19457575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.
    LaBuda CJ; Koblish M; Little PJ
    Eur J Pharmacol; 2005 Dec; 527(1-3):172-4. PubMed ID: 16316653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids: occurrence and medicinal chemistry.
    Appendino G; Chianese G; Taglialatela-Scafati O
    Curr Med Chem; 2011; 18(7):1085-99. PubMed ID: 21254969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
    Svízenská I; Dubový P; Sulcová A
    Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
    del Río C; Navarrete C; Collado JA; Bellido ML; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Pollastro F; Appendino G; Calzado MA; Cantarero I; Muñoz E
    Sci Rep; 2016 Feb; 6():21703. PubMed ID: 26887982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest progress in the identification of novel synthetic ligands for the cannabinoid CB2 receptor.
    Han S; Chen JJ; Chen JZ
    Mini Rev Med Chem; 2014 May; 14(5):426-43. PubMed ID: 24766386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.